Home/Health Plans/Employers/OnTrak Members/Contact Us
/
         
Blog Home  
  » Home  
  Recent Posts  
   
 
  Blog Calendar  
 
SuMoTuWeThFrSa
   1234
567891011
12131415161718
19202122232425
262728293031 
 
  Catasys Newsletter  
  Get the latest in healtcare news. » Sign Up Now  

Welcome to the Catasys On Healthcare Blog
Substance dependence drives significant health care costs for payors through a combination of factors that include acute inpatient utilization and unaddressed co-morbidities. The Substance Dependence problem is pervasive, largely untreated and costly. Stay informed on these topics by visiting our blog periodically. You can also sign up for the Catasys On Healthcare Newsletter to receive the latest in health care news. » Sign Up for Newsletter


Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy of Flumazenil and Gabapentin in Reducing Craving and Use During use during Initial Treatment of Methamphetamine Dependence

Catasys Health - Wednesday, November 25, 2009

Harold Urschel, Research Across America, Dallas, Texas
Published in the Journal of Psychopharmacology, November 25, 2009
 ยป More




| 1 |

 

 
  Tags
 
predictive modeling meth over-the-counter substances medical and behavioral costs craving score drug addiction Raymond Anton hydrocodone recovery network pain medication marijuana Journal of Psychopharmacology opioid-drug interactions Harold Urschel morphine behavioral healthcare health plan psychosocial drug treatment drug overdose Research Across America health reform OnTrak cocaine placebo substance use disorder depression mental health stratified hospital Opioid Treatment opioid addiction treatment methamphetamine dependence mental illness relapse gabapentin cocaine treatment binge drinking OxyContin overdose double-blind behavioral health behavioral healthcare services methamphetamine SD health insurance drug abuse data mining Catasys prometa high-utilizing alcoholism contract substance dependence costs trauma alcohol opiates opioid abuse SD members alcohol drinking social network naloxone sugar depression screening codeine addiction treatment anxiety recovery post-traumatic stress disorder diabetes reduction in use communication reduction in craving vivitrol sobriety medical health insurance randomized drug use reducing craving Health Care Utilization stimulants smoking substance dependence physician- patient relations drinking pain pills sober chronic pain PTSD craving dependence issues heroin hospitalizations painkillers opioid antagonist percocet Co Occurring Disorders methadone oxycodone identification alcohol dependence prescriptions behavioral health care services withdrawal emergency room medical costs suboxone stress ADD bipolar disorder addict UnitedHealthcare Opioid Prescribing placebo-controlled ER urine drug screen opiod abuse opioid overdose ADHD primary care facebook muscle relaxant buprenorphine relapse prevention nicotine care coaching behavioral health care cigarettes alcohol treatment fentanyl substance dependence health insurance opiod-based flumazenil Opioid Medications narcotic CIWA vicodin pain killers drug addicts
  Call Us Today
  866-517-1414
         
 
 
Home/News/Press/Investor Relations/Careers/BlogContact Us/Site Index/Privacy Policy/Photo Disclaimer
 
  Copyright © 2013 Catasys. All rights reserved. | 11150 Santa Monica Blvd., Suite 1500, Los Angeles, California 90025 | Toll Free: 1-866-517-1414